Medtronic (MDT) EBT Margin (2014 - 2026)
Medtronic recorded quarterly EBT Margin of 15.57% in Q1 2026, down 12.63% quarter-over-quarter from 17.82% in Q4 2025, and down 300.0% year-over-year from 7.79% in Q1 2025.
Medtronic's EBT Margin history runs 13 years deep, the most recent figure standing at 15.57% for Q1 2026.
- In Q1 2026, EBT Margin fell 300.0% year-over-year to 15.57%; the TTM figure through Jan 2026 stood at 15.68% (down 5.0% YoY), while the FY2025 annual figure was 16.78%, up 184.0% from the prior year.
- EBT Margin came in at 15.57% for Q1 2026 at Medtronic, down from 17.82% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 20.47% in Q1 2022 to a low of 9.95% in Q2 2024.
- A 5-year average of 16.75% and a median of 17.79% in 2023 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin jumped 478 bps in 2022 and slumped 820 bps in 2024, its largest moves.
- Medtronic's EBT Margin stood at 18.39% in 2022, then retreated by 11 bps to 16.45% in 2023, then increased by 13 bps to 18.55% in 2024, then slipped by 4 bps to 17.82% in 2025, then retreated by 13 bps to 15.57% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 15.57%, 17.82%, and 15.18% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 15.57% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 27.84% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4.87% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 22.61% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.84% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.17% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 14.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 23, 2026 | 15.57% |
| Oct 24, 2025 | 17.82% |
| Jul 25, 2025 | 15.18% |
| Apr 25, 2025 | 14.13% |
| Jan 24, 2025 | 18.57% |
| Oct 25, 2024 | 18.55% |
| Jul 26, 2024 | 16.02% |
| Apr 26, 2024 | 9.95% |
| Jan 26, 2024 | 18.20% |
| Oct 27, 2023 | 16.45% |
| Jul 28, 2023 | 15.53% |
| Apr 28, 2023 | 18.15% |
| Jan 27, 2023 | 17.79% |
| Oct 28, 2022 | 18.39% |
| Jul 29, 2022 | 14.16% |
| Apr 29, 2022 | 19.80% |
| Jan 28, 2022 | 20.47% |
| Oct 29, 2021 | 19.03% |
| Jul 30, 2021 | 10.43% |
| Apr 30, 2021 | 19.13% |
| Jan 29, 2021 | 15.69% |
| Oct 30, 2020 | 6.87% |
| Jul 31, 2020 | 8.97% |
| Apr 24, 2020 | 3.42% |
| Jan 24, 2020 | 20.46% |
| Oct 25, 2019 | 16.79% |
| Jul 26, 2019 | 13.04% |
| Apr 26, 2019 | 15.86% |
| Jan 25, 2019 | 18.16% |
| Oct 26, 2018 | 18.11% |
| Jul 27, 2018 | 15.98% |
| Apr 27, 2018 | 21.18% |
| Jan 26, 2018 | 13.94% |
| Oct 27, 2017 | 24.51% |
| Jul 28, 2017 | 16.17% |
| Apr 28, 2017 | 18.13% |
| Jan 27, 2017 | 13.28% |
| Oct 28, 2016 | 16.50% |
| Jul 29, 2016 | 13.79% |
| Apr 29, 2016 | 14.99% |
| Jan 29, 2016 | 17.00% |
| Oct 30, 2015 | 15.34% |
| Jul 31, 2015 | 12.92% |
| Apr 24, 2015 | 2.56% |
| Jan 23, 2015 | 27.65% |
| Oct 24, 2014 | 23.41% |
| Jul 25, 2014 | 25.35% |